MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11

Usama Ashraf1,2,3,4, Bibo Zhu1,2,3,4, Jing Ye1,2,3,4

  • 1State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, Hubei, People's Republic of China.

Journal of Virology
|March 4, 2016
PubMed
Abstract

Insights

MicroRNA miR-19b-3p promotes Japanese encephalitis virus (JEV) induced neuroinflammation by targeting RNF11. Inhibiting miR-19b-3p in mice reduces inflammation, neuronal death, and improves survival.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Japanese encephalitis virus (JEV) causes neuroinflammation and neuronal damage.
  • MicroRNAs (miRNAs) are key regulators of inflammatory responses.
  • The role of astrocytic miRNAs in JEV-induced inflammation is not well understood.

Purpose of the Study:

  • To investigate the role of miR-19b-3p in JEV-induced neuroinflammation.
  • To elucidate the molecular mechanism by which miR-19b-3p regulates JEV-induced inflammation.
  • To evaluate the therapeutic potential of targeting miR-19b-3p in JEV infection.

Main Methods:

  • In vitro and in vivo experiments using cell cultures and mouse models of JEV infection.
  • Quantification of miR-19b-3p levels, inflammatory cytokines, and RNF11 expression.
  • Overexpression and knockdown of miR-19b-3p.
  • Administration of miR-19b-3p-specific antagomir in vivo.
  • Assessment of neuronal cell death and survival rates.

Main Results:

  • miR-19b-3p is upregulated in JEV-infected cells and mouse brains.
  • Overexpression of miR-19b-3p enhances JEV-induced inflammatory cytokine production.
  • miR-19b-3p targets ring finger protein 11 (RNF11), a negative regulator of NF-κB signaling.
  • Inhibition of miR-19b-3p reduces neuroinflammation, gliosis, neuronal death, and improves survival in JEV-infected mice.

Conclusions:

  • miR-19b-3p positively regulates JEV-induced inflammatory response by targeting RNF11 and activating NF-κB signaling.
  • Targeting miR-19b-3p offers a potential therapeutic strategy for JEV-induced encephalitis.

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
10
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

12.0K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.5K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.6K